Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Author: Lisa Levin | September 20, 2023 06:23am

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

  • ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) shares dipped 46.8% to $3.51 in pre-market trading after the FDA issued a Complete Response Letter for ARS Pharma's neffy® Epinephrine nasal spray, with request for additional study.
  • Revance Therapeutics, Inc. (NASDAQ:RVNC) shares declined 5.8% to $13.01 in pre-market trading. Revance Therapeutics shares fell 17% on Tuesday after the company said it commenced a plan to exit the OPUL payments business and expects to record a restructuring charge of up to $7 million.
  • Instacart (Maplebear Inc.) (NASDAQ:CART) shares fell 4.4% to $32.21 in pre-market trading after gaining 12% on Tuesday. Instacart priced its IPO at $30 per share late Monday, which was at the top end of the expected range. Needham initiated coverage on Maplebear with a Hold rating.
  • Meta Data Limited (NYSE:AIU) shares fell 4% to $0.96 in pre-market trading after declining around 5% on Tuesday.
  • Nikola Corporation (NASDAQ:NKLA) shares declined 3.2% to $1.50 in pre-market trading. Nikola recently announced the appointment of a new chief operating officer.
  • Toyota Motor Corporation (NYSE:TM) shares fell 2.6% to $190.06 in pre-market trading after adding 3% on Tuesday.

Now Read This: Fear & Greed Index Remains In 'Neutral' Zone Ahead Of Fed Decision

Don’t forget to check out our premarket coverage here

Posted In: AIU CART NKLA RVNC SPRY TM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist